Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0021 | 0.0051 | 0.0051 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0357 | 0.0308 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0357 | 0.0308 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0357 | 0.0308 |
Leishmania major | trypanothione reductase | 0.0061 | 0.041 | 0.0361 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0061 | 0.041 | 0.0361 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0536 | 0.4684 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0357 | 0.0357 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0061 | 0.041 | 0.0361 |
Treponema pallidum | NADH oxidase | 0.0021 | 0.0051 | 0.5 |
Loa Loa (eye worm) | glutathione reductase | 0.0061 | 0.041 | 0.0054 |
Brugia malayi | Thioredoxin reductase | 0.0061 | 0.041 | 0.041 |
Brugia malayi | hypothetical protein | 0.0536 | 0.4684 | 0.4684 |
Toxoplasma gondii | thioredoxin reductase | 0.0061 | 0.041 | 0.0361 |
Brugia malayi | glutathione reductase | 0.0061 | 0.041 | 0.041 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0357 | 0.0308 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0021 | 0.0051 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0536 | 0.4684 | 0.4657 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0357 | 0.0308 |
Plasmodium vivax | glutathione reductase, putative | 0.0061 | 0.041 | 0.0361 |
Trypanosoma brucei | trypanothione reductase | 0.0061 | 0.041 | 0.0361 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0061 | 0.041 | 0.0054 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0357 | 0.0308 |
Plasmodium falciparum | glutathione reductase | 0.0061 | 0.041 | 0.0361 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0021 | 0.0051 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0357 | 0.0308 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0021 | 0.0051 | 0.5 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0061 | 0.041 | 0.0361 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0536 | 0.4684 | 0.4657 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0061 | 0.041 | 0.0361 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0021 | 0.0051 | 0.5 |
Plasmodium falciparum | thioredoxin reductase | 0.0061 | 0.041 | 0.0361 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0061 | 0.041 | 0.0361 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.4716 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.